CY1106201T1 - Αναλογα δισκοδepμολιδης και η φαρμακευτικη τους χρηση - Google Patents

Αναλογα δισκοδepμολιδης και η φαρμακευτικη τους χρηση

Info

Publication number
CY1106201T1
CY1106201T1 CY20061101483T CY061101483T CY1106201T1 CY 1106201 T1 CY1106201 T1 CY 1106201T1 CY 20061101483 T CY20061101483 T CY 20061101483T CY 061101483 T CY061101483 T CY 061101483T CY 1106201 T1 CY1106201 T1 CY 1106201T1
Authority
CY
Cyprus
Prior art keywords
discodepmolide
analogues
pharmaceutical use
formula
specific
Prior art date
Application number
CY20061101483T
Other languages
Greek (el)
English (en)
Inventor
Kenneth Walter Bair
Frederick Ray KINDER JR.
Timothy Michael Ramsey
Michael Lloyd Sabio
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1106201T1 publication Critical patent/CY1106201T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
CY20061101483T 2001-11-16 2006-10-16 Αναλογα δισκοδepμολιδης και η φαρμακευτικη τους χρηση CY1106201T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33239901P 2001-11-16 2001-11-16
US34339401P 2001-12-21 2001-12-21

Publications (1)

Publication Number Publication Date
CY1106201T1 true CY1106201T1 (el) 2011-06-08

Family

ID=26988201

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101483T CY1106201T1 (el) 2001-11-16 2006-10-16 Αναλογα δισκοδepμολιδης και η φαρμακευτικη τους χρηση

Country Status (9)

Country Link
US (2) US6833367B2 (enExample)
EP (1) EP1312608B1 (enExample)
JP (1) JP4410986B2 (enExample)
AT (1) ATE334977T1 (enExample)
CY (1) CY1106201T1 (enExample)
DE (1) DE60213541T2 (enExample)
DK (1) DK1312608T3 (enExample)
ES (1) ES2267928T3 (enExample)
PT (1) PT1312608E (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005084349A2 (en) * 2004-03-02 2005-09-15 Kosan Biosciences, Inc. Compounds useful for the synthesis of (+)-discodermolide and methods therefor
US7214708B2 (en) * 2004-11-18 2007-05-08 Kosan Biosciences Incorporated Synthetic discodermolide analogs
FR2951720B1 (fr) * 2009-10-28 2011-12-16 Pf Medicament Molecules polyketides comme agents anticancereux
US8476432B2 (en) * 2010-07-01 2013-07-02 Yuhan Corporation Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010099A (en) * 1989-08-11 1991-04-23 Harbor Branch Oceanographic Institution, Inc. Discodermolide compounds, compositions containing same and method of preparation and use
US5681847A (en) * 1995-12-05 1997-10-28 Harbor Branch Oceanographic Institution, Inc. Methods of using discodermolide compounds
US5789605A (en) 1996-12-03 1998-08-04 Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof
US6870058B2 (en) 1996-12-03 2005-03-22 The Trustees Of The University Of Pennsylvania Compounds which mimic the chemical and biological properties of discodermolide
US6242616B1 (en) 1996-12-03 2001-06-05 The Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
US6096904A (en) 1996-12-03 2000-08-01 The Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
US6127406A (en) * 1998-10-09 2000-10-03 Harbor Branch Oceanographic Institution, Inc. Discodermolide compounds and methods of use
DE60108359T2 (de) * 2000-03-01 2005-12-22 Harbor Branch Oceanographic Institution, Inc., Fort Pierce Biologisch wirksame, analoge verbindungen von discodermoliden

Also Published As

Publication number Publication date
EP1312608A2 (en) 2003-05-21
JP2003160575A (ja) 2003-06-03
US20050080080A1 (en) 2005-04-14
DK1312608T3 (da) 2006-11-27
JP4410986B2 (ja) 2010-02-10
US7148218B2 (en) 2006-12-12
DE60213541T2 (de) 2007-10-04
PT1312608E (pt) 2006-12-29
ES2267928T3 (es) 2007-03-16
ATE334977T1 (de) 2006-08-15
US6833367B2 (en) 2004-12-21
EP1312608B1 (en) 2006-08-02
DE60213541D1 (de) 2006-09-14
EP1312608A3 (en) 2003-06-18
US20030153601A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
CY1109309T1 (el) Παραγωγα γλυκοπυρανοσυλοξυπυραζολης και χρηση αυτων σε φαρμακευτικα σκευασματα
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
CY1113105T1 (el) Παραγωγα ξανθινης, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
NO2017022I2 (no) Obetikolsyre
CY1107634T1 (el) Φαρμακευτικη συνθεση
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
CY1105575T1 (el) Ενωσεις αμιδιου και χρηση αυτων
CY1110600T1 (el) Αναλογα της βιταμινης d
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
ATE464299T1 (de) Neues phenylalaninderivat
PT1263724E (pt) Novos compostos
SE0102617D0 (sv) Novel compounds
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
NO20042534L (no) Forbedringer vedrorende optiske lysgjoringsmidler
FR2834890B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
EA200300334A1 (ru) Новая соль периндоприла и содержащие ее фармацевтические композиции
DE60219911D1 (de) Pyrrolidin-2-on derivate als faktor xa inhibitoren
PT1181294E (pt) Novos derivados e analogos da galantamina
SE9901077D0 (sv) Novel use
AP1795A (en) Peptide deformylase inhibitors.
SE0102716D0 (sv) Novel compounds
SE0101322D0 (sv) Novel compounds
BR0205812A (pt) Benzimidazois úteis no tratamento da disfunção sexual
HUP0302441A2 (hu) Antibiotikus hatású gyógyászati készítmények
SE9801494D0 (sv) Novel use